Cargando…

Proadrenomedullin in the Management of COVID-19 Critically Ill Patients in Intensive Care Unit: A Systematic Review and Meta-Analysis of Evidence and Uncertainties in Existing Literature

Mid-regional proadrenomedullin (MR-proADM) is a new biomarker of endothelial damage and its clinical use is increasing in sepsis and respiratory infections and recently in SARS-CoV-2 infection. We conducted a systematic review and meta-analysis to clarify the use of MR-proADM in severe COVID-19 dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montrucchio, Giorgia, Balzani, Eleonora, Lombardo, Davide, Giaccone, Alice, Vaninetti, Anna, D’Antonio, Giulia, Rumbolo, Francesca, Mengozzi, Giulio, Brazzi, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369672/ https://www.ncbi.nlm.nih.gov/pubmed/35956159 http://dx.doi.org/10.3390/jcm11154543

Ejemplares similares

Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study
por: Montrucchio, Giorgia, et al.
Publicado: (2023)

Prognostic Value of Mid-Regional Proadrenomedullin Sampled at Presentation and after 72 Hours in Septic Patients Presenting to the Emergency Department: An Observational Two-Center Study
por: Bima, Paolo, et al.
Publicado: (2022)

Trichoderma spp.-Related Pneumonia: A Case Report in Heart–Lung Transplantation Recipient and a Systematic Literature Review
por: Burzio, Carlo, et al.
Publicado: (2023)

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

Effects of Steroids and Tocilizumab on the Immune Response Profile of Patients with COVID-19-Associated ARDS Requiring or Not Veno-Venous Extracorporeal Membrane Oxygenation
por: Fanelli, Vito, et al.
Publicado: (2021)

Pneumocystis jirovecii Pneumonia after Heart Transplantation: Two Case Reports and a Review of the Literature
por: Burzio, Carlo, et al.
Publicado: (2023)

Antimicrobial Prophylaxis in Extracorporeal Membrane Oxygenation: Is the Debate Still Open?
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis
por: Fahmey, Sameh Samir, et al.
Publicado: (2018)

Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity
por: Andaluz-Ojeda, David, et al.
Publicado: (2017)

A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold
por: Lupia, Tommaso, et al.
Publicado: (2022)

SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

Prospective diagnostic accuracy study of plasma soluble ST2 for diagnosis of acute aortic syndromes
por: Morello, Fulvio, et al.
Publicado: (2020)

Prognostic value of proadrenomedullin in patients with COVID-19 pneumonia
por: Astapovskii, Aleksandr A., et al.
Publicado: (2022)

Proadrenomedullin in Sepsis and Septic Shock: A Role in the Emergency Department
por: Piccioni, Andrea, et al.
Publicado: (2021)

Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements
por: Montrucchio, G., et al.
Publicado: (2021)

Proadrenomedullin and copeptin in pediatric pneumonia: a prospective diagnostic accuracy study
por: Alcoba, Gabriel, et al.
Publicado: (2015)

MR-Proadrenomedullin as biomarker of renal damage in urinary tract infection in children
por: Peñalver Penedo, Rafael, et al.
Publicado: (2021)

The Anesthesiologist's Perspective Regarding Non-intubated Thoracic Surgery: A Scoping Review
por: Rosboch, Giulio Luca, et al.
Publicado: (2022)

Optimal Management for Stage IVB Endometrial Cancer: A Systematic Review
por: Capozzi, Vito Andrea, et al.
Publicado: (2023)

Effectiveness of an Active and Continuous Surveillance Program for Intensive Care Units Infections Based on the EPIC III (Extended Prevalence of Infection in Intensive Care) Approach
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Usefulness of Midregional Proadrenomedullin to Predict Poor Outcome in Patients with Community Acquired Pneumonia
por: Gordo-Remartínez, Susana, et al.
Publicado: (2015)

Mid-Regional Proadrenomedullin as a New Biomarker of Kidney and Cardiovascular Diseases—Is It the Future?
por: Czajkowska, Katarzyna, et al.
Publicado: (2021)

Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients
por: Indirli, Rita, et al.
Publicado: (2022)

The role of proadrenomedullin, interleukin 6 and CD64 in the diagnosis and prognosis of septic shock
por: Turan, Yasemin Bozkurt
Publicado: (2023)

Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia
por: Suberviola, B, et al.
Publicado: (2011)

Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination
por: Angeletti, Silvia, et al.
Publicado: (2015)

Acute exacerbations of copd (AECOPD) in the emergency room (ER): prognostic value of proadrenomedulline (PROADM)
por: Dres, M, et al.
Publicado: (2015)

Prognostic value of serum proadrenomedullin in catheter-related bloodstream infection in the intensive care unit: A prospective observational study
por: Ni, Juping, et al.
Publicado: (2018)

Ceftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing Klebsiella pneumoniae in ICU Setting: We Are What We Are Treated with?
por: Corcione, Silvia, et al.
Publicado: (2023)

The Role of Mid-Regional Proadrenomedullin in the Differential Diagnosis between Culture-Negative and Culture-Positive Sepsis at Emergency Department Admission
por: Mearelli, Filippo, et al.
Publicado: (2022)

Bloodstream Infections Caused by Carbapenem-Resistant Pathogens in Intensive Care Units: Risk Factors Analysis and Proposal of a Prognostic Score
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

First Cases of Candida auris in a Referral Intensive Care Unit in Piedmont Region, Italy
por: Corcione, Silvia, et al.
Publicado: (2022)

Initial levels of mr-proadrenomedullin: a predictor of severity in patients with influenza a virus pneumonia
por: Valenzuela Sanchez, F, et al.
Publicado: (2015)

Diagnostic and Prognostic Validity of Proadrenomedullin among Neonates with Sepsis in Tertiary Care Hospitals of Southern India
por: Kannan, Raja, et al.
Publicado: (2018)

Proadrenomedullin in Patients with Preserved Left Ventricular Systolic Function Undergoing Coronary Artery Bypass Grafting
por: Stanisz-Kempa, Joanna, et al.
Publicado: (2022)

Patient experience of uncertainty in cancer genomics: a systematic review
por: Bartley, Nicci, et al.
Publicado: (2020)

Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up
por: Buendgens, Lukas, et al.
Publicado: (2020)

Mid-regional proadrenomedullin, C-terminal proendothelin-1 values, and disease course are not different in critically ill SARS-CoV-2 pneumonia patients with obesity
por: van Oers, Jos A. H., et al.
Publicado: (2022)

The Role of Measurement Uncertainty in Health Technology Assessments (HTAs) of In Vitro Tests
por: Smith, Alison F., et al.
Publicado: (2018)

A Pilot Study on the Diagnostic Accuracy of Proadrenomedullin and Proatrial Natriuretic Peptide in Lower Respiratory Tract Infections
por: Ruiz-González, Agustín, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4pnbbu2g05tqrn3ck92an8m544